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The combined consumption of acetaminophen (APAP) and ethanol (EtOH) has been an issue 
with clinical implications.  Previous findings regarding the simultaneous consumption of APAP 
and EtOH have reported harmful effects on the liver and stomach; however, little is known about 
the effects on the central nervous system (CNS).  We hypothesized that EtOH and APAP will 
have a synergistic effect on the CNS of Daphnia magna (D. magna), causing a pronounced 
decrease in heart rate at a toxic dose of EtOH.  To better understand the effects of the combined 
consumption of EtOH and APAP on the CNS, the heart rates of D. magna were measured under 
a  dissection  microscope  after  exposure  to  EtOH,  APAP,  or  a  combined  EtOH-APAP 
solution.  Interestingly, the average heart rates of D. magna exposed to the EtOH-APAP solution 
and D. magna exposed only to APAP were approximately the same.  Although our results did 
not support our original hypothesis, the data demonstrated that APAP exerted a dominant effect 
over EtOH.  APAP and EtOH are known to have inhibitory effects on the CNS.  Therefore, these 
findings suggest that APAP and EtOH may compete against each other on similar pathways to be 
the substance that exerts an inhibitory effect in the CNS. 
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Introduction 
 
    Acetaminophen  (APAP)  is  a  common 
ingredient in over-the-counter painkillers such as 
Tylenol®.  It is used to relieve headaches, fevers, 
and general aches.  When used as directed, the 
effects  are  generally  considered  harmless.  
However, the FDA advises against taking APAP 
in  conjunction  with  other  substances, 
particularly  alcohol  (U.S.  Food  and  Drug 
Administration, 2003).  Combining APAP and 
ethanol  (EtOH)  is  a  common  mistake  among 
consumers,  who  are  often  unaware  of  its 
consequences (Prescott, 1999).  Side effects are 
seen in the liver and stomach (Maze et al., 1998), 
but are unknown in the central nervous system. 
    The nervous system can be affected by 
chemicals that act as depressants or stimulants, 
either  to  slow  or  accelerate  processes  in  the 
brain and body.  The medulla oblongata, part of 
the  brain  stem,  is  responsible  for  autonomic 
body functions including the control of heart rate 
(Korpelainin et al., 1999). 
  The  organism  D.  magna  is  an  ideal 
specimen to use to study the effects of chemical 
substances on the nervous system.  D. magna are 
filter feeders normally found in temperate fresh 
waters (Soares et al., 2008).  The heart of a D. 
magna  is  easily  viewed  under  a  dissection 
microscope due to its transparent body, making 
it  well-suited  for  this  experiment  (Chapman, 
1976).    As  its  heart  rate  is  modified  by  the 
nervous system (McMahon, 2001), the heart is a 
useful  organ  to  study  in  order  to  further 
understand  the  effects  of APAP  and  EtOH  on 
the nervous system. In addition, the heart of D. 
magna behaves like a vertebrate heart (Bekker 
and Krijsgman, 1951) and is thus comparable to 
the human heart. 
In  addition  to  its  analgesic  effects, 
APAP  also  acts  as  a  depressant  on  the  CNS.  
More  specifically,  APAP  is  believed  to 
demonstrate a positive effect on the serotonergic 
descending  inhibitory  pathways  (Smith  et  al., 
2009),  thereby  producing  its  analgesic  effects.  
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its  related  pathways  are  highly  responsive  to 
APAP  (Anderson,  2008).    Analgesics  work  by 
inducing  the  release  of  opioid  peptides,  which 
activate  the  descending  inhibitory  system  in  the 
spinal cord (Mukaida et al., 2007).  Between the 
inhibitory  effects  and  the  release  of  the  opioid 
peptides, physiological reactions to APAP have 
an overall depressant effect.  There is thus an 
inhibitory  reaction  to  APAP  in  all  bodily 
functions controlled by the brain stem and spinal 
cord,  including  the  heart  rate.    It  has  been 
reported  that  APAP  causes  antiarrhythmic 
effects  on  the  heart  of the  dog  (Merrill  et  al., 
2007) and causes an increase in cardiac output 
and mean arterial pressure in sheep (Leshnower 
et al., 2006)  
Another commonly used effector of the 
CNS  is  EtOH.    Typically  EtOH  triggers  an 
increase  in  rate  heart.  Previously,  it  has  been 
shown that alcohol causes marked tachycardia in 
erect  and  supine  postures  (Scott  et  al.,  1987).  
While  EtOH  triggers  an  increased  heart  rate, 
consumption of a toxic dose of EtOH may cause 
bradycardia. It has been demonstrated that upon 
administration of EtOH to female rats, there is a 
corresponding  decrease  in  mean  arterial  blood 
pressure (El-Mas et al., 2005).  Further research 
indicates  that  EtOH  acts  as  an  agonist  on 
GABAergic  receptors;  inducing  inhibitory 
postsynaptic potentials in postsynaptic neurons 
(Theile et al., 2008).  
The  goal  of  this study  is to  determine 
how APAP and EtOH affect the nervous system 
when  taken  simultaneously.    The  commercial 
alcoholic beverage, Absolut™ Vodka 80 proof, 
was  used  in  place  of  laboratory  grade  EtOH 
because  it  is  more  similar  to  what  individuals 
would consume on a college campus.  There are 
known side effects in the stomach and liver, but 
there  is  little  research  on  the  effects  of  this 
combination  in  the  nervous  system.    Our 
hypothesis  is  that  EtOH  and  APAP  will  act 
synergistically on the CNS of D. magna causing 
a pronounced decrease in heart rate, mimicking 
consumption levels of a toxic dose that would 
result in heart rate depression.   
 
 
 
 
Materials and Methods 
 
Optimal Concentration Determination 
D.  magna  were  placed  on  Vaseline™-
coated depression slides with 0.171 M, 0.342 M, 
or  0.684  M  EtOH  solutions  to  determine  the 
optimal  EtOH  concentration.    Optimal 
concentration  is  defined  as  the  highest 
concentration of the medium that did not result 
in lethality.  After five minutes of acclimation in 
the  solution,  the  heart  beats  of  the  D.  magna 
were  observed  under  a  dissection  microscope.  
Ten trials were used to determine optimal EtOH 
concentration.    The  same  procedure  was 
repeated  for  32  mg/mL,  3.2  mg/mL,  and  0.32 
mg/mL  APAP  solutions  to  determine  the 
optimal  APAP  concentration.    All  D.  magna 
used in this trial were used once and only in this 
trial.  Trials were conducted at 20-22 °C. 
 
Heart Rate 
D.  magna  were  transferred  from  a 
culture  of  wild  D.  magna  (Ward’s  Natural 
Science, Rochester, NY) to a Vaseline™-coated 
Fisher-brand depression slide (Fisher Scientific, 
Pittsburgh,  PA).    After  five  minutes  of 
acclimation  on  the  slide,  its  heart  beats  were 
counted for two minutes under a Nikon SMZ645 
dissection  microscope  (Nikon,  Melville  NY) 
using a manual palm counter (Fisher Scientific, 
Pittsburgh,  PA)  and  a  digital  timer  (Fisher 
Scientific, Pittsburgh, PA).  The heart rates of 
ten D. magna were counted, using five trials for 
each  D.  magna.    In  this  procedure  and  the 
procedures  listed  below,  each  D.  magna  was 
kept  in  a  liquid  medium  at  all  times.  All  D. 
magna used in this trial were used only in this 
trial.  Trials were conducted at 20-22 °C. 
 
Ethanol Treatment 
    D.  magna  were  transferred  to  a 
Vaseline™-coated  depression  slide.    Excess 
water  was  removed  while  0.342  M  EtOH 
(Absolut™  Vodka,  80  Proof,  40%  EtOH  by 
volume,  produced  by  Pernod  Ricard,  Paris, 
France) was added immediately afterwards.  The 
D. magna were allowed to acclimate to the new 
medium on the depression slide for five minutes.  
Their heart rate was then measured following the 
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trial  were used  only  in this  trial.    Trials  were 
conducted at 20-22 °C. 
 
Acetaminophen Treatment 
D. magna were placed in a container of 
3.2  mg/mL  liquid  APAP  (Children’s 
acetaminophen  oral  suspension  liquid,  32 
mg/mL, Target Corporation, Minneapolis, MN) 
for  two  minutes.    D.  magna  were  then 
transferred to an untreated slide in which excess 
APAP was removed while deionized water was 
immediately  added.    This  exchange  was 
performed to improve visibility of the heart due 
to the cloudy nature of APAP.  The D. magna 
were  then  transferred  to  a  Vaseline™  coated 
depression  slide.    The  protocol  for  measuring 
heart  rate  was  the  same  used  in  the  control 
procedure.  All D. magna used in this trial were 
used only in this trial.  Trials were conducted at 
20-22 °C. 
 
Ethanol and Acetaminophen Combined 
Treatment 
D.  magna  were  placed  in  a  mixed 
solution  of  0.342  M  EtOH  and  3.2  mg/mL 
APAP  (EtOH-APAP)  for  five  minutes.    After 
the five minute incubation period, the D. magna 
were placed on a Vaseline™-coated depression 
slide with deionized water in order to improve 
visibility of the heart.  Following a two minute 
acclimation  period,  the  heart  rate  was counted 
using  the  control  procedures.  All  D.  magna 
used  in  this  trial  were  used  only  in  this  trial.  
Trials were conducted at 20-22 °C.  
 
Statistical Analysis 
  Microsoft  Office  Excel  2007  with  the 
Data  Analysis  add-in  tool  pack  was  used  to 
determine F, T, and P values for each dataset. 
 
Results 
 
Optimal Concentration Determination 
The average heart rate of untreated D. 
magna,  measured  in  beats  per  minute  (bpm), 
was 221.06  5.75 bpm, n = 50 (average  SEM, 
n = number of subjects) (Fig. 1), was used as the 
control throughout the rest of this study.  EtOH 
and APAP both demonstrated inhibitory effects 
on the D. magna heart rate; as the APAP and 
EtOH  concentration  increased,  the  heart  rate 
dropped  drastically  (Fig.  1).    D.  magna 
administered  with  0.171  M  EtOH  experienced 
the  least  change  in  heart  rate  (176.20 
bpm,  n  =  10)  when  compared  to  the 
control group.  The 0.342 M EtOH concentration 
had  the  most  influence  on  heart  rate (97.30  
12.62 bpm, n = 10).  The highest concentration, 
0.648 M EtOH, resulted in 90% lethality, with 
the surviving individual expressing a heart rate 
of  28  bpm,  n  =  10  (Fig.  1A).    Similarly,  D. 
magna  administered  with  0.32  mg/mL  APAP 
concentration  showed  the  least  amount  of 
change in heart rate (179.2  18.0 bpm, n = 10) 
in comparison to the control group.  D. magna 
treated  with  3.2  mg/mL  APAP  exhibited  the 
largest  change  in  heart  rate  without  lethality 
(151.5  30.9 bpm, n = 10) in comparison to the 
control.  The 32 mg/mL concentration of APAP 
was lethal for all D. magna (Fig. 1B).  
 
 
 
 
Figure  1.    D.  magna  heart  rate  response  to  varying 
concentrations  of  EtOH  and  APAP,  n  =  10  at  each 
condition.  A, Compared to control average heart rate, an 
EtOH  concentration  of  0.171  M  demonstrated  a  slightly 
decreased  heart  rate (F  =  4.61, t  stat  =  5.28, P(F<≤f)  = 
0.009, P(T<≤t) = 1.15 x 10
-5), 0.342 M EtOH resulted in 
the largest decrease in heart rate (F = 4.63, t stat = 14.80, 
P(F≤f) = 0.009, P(T≤t) = 2.37 x 10
-15) with no lethality, 
0.648 M EtOH resulted in 90% lethality.  B, Compared to 
control average heart rate, an APAP concentration of 0.32 
mg/mL demonstrated slightly decreased heart rate (F = 3.93, 
t stat = 4.71, P(F<≤f) = 0.016, P(T≤t) = 3.57 x 10
-5), 3.2 
mg/mL APAP had the greatest decrease in heart rate (F = 
1.21, t stat = 4.94, P(F≤f) = 0.401, P(T≤t) = 3.53 x 10
-6) 
without  resulting  in  lethality,  32  mg/mL  resulted  in 
lethality for all D. magna. Page 4 of 6 
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Ethanol and/or Acetaminophen Treatment 
D. magna administered with 3.2 mg/mL 
APAP  experienced  an  average  heart  rate  of 
153.03  5.11 bpm, n = 50.  Individuals exposed 
to APAP demonstrated a slightly non-rhythmic 
heart rate.  D. magna exposed to 0.342 M EtOH 
experienced a decreased heart rate of 107.04  
3.10 bpm.  Individuals treated with EtOH also 
exhibited  a  slightly  non-rhythmic  heart  rate.  
The average heart rate of D. magna treated with 
both 3.2 mg/mL APAP and 0.342 M EtOH was 
160.75 ± 7.35 bpm (Fig. 2).   The average heart 
rate when tested with the EtOH-APAP solution 
was  lower  than  the  average  heart  rate  of  the 
control group, but was higher than the average 
heart  rates  of  D.  magna  tested  with  APAP  or 
EtOH individually (Fig. 2).  There was a more 
evident  non-rhythmic  heart  rate  seen  in  D. 
magna  exposed  to  the  EtOH-APAP  combined 
solution.   
 
Figure  2.    Heart  rate  of  D.  magna  in  various  treatment 
conditions.  D. magna had the most pronounced heart rate 
decrease (F = 3.44, t stat = 17.29, P(F≤f) = 1.51 x 10
-5, 
P(T≤t) = 3.38 x 10
-28) in 0.342 M EtOH solution compared 
to the control.  The heart rate responses to the 3.2 mg/mL 
APAP or EtOH-APAP (.342 M + 3.2mg/mL) solution were 
similar (F = 2.07, t stat = 0.75, P(F≤f) = 0.006, P(T≤t) = 
0.227), with the heart rates in both conditions less than that 
of the control (APAP, F = 1.27, t stat =  8.71, P(F≤f) = 
0.206, P(T≤t) = 1.660; EtOH-APAP, F = 0.61, t stat = 6.36, 
P(F≤f) = 0.044, P(T≤t) = 3.29 x 10
-9).  Starred values show 
that  APAP  and  EtOH+APAP  are  significantly  similar  to 
each other.  
 
Conclusions 
 
The  D.  magna  treated  with  the 
combined  solution  of  0.342  M  EtOH  and  3.2 
mg/mL APAP had a similar heart rate to the D. 
magna treated with 3.2 mg/mL APAP alone.  On 
the  other  hand,  D.  magna  treated  with  EtOH 
alone had a pronounced decrease in heart rate as 
compared to APAP- or EtOH-treated D. magna, 
as well as compared to controls.  Untreated D. 
magna, used as the control group, expressed an 
average heart rate of 221.06 ± 5.75 bpm.  This 
agrees  with  previous  experimental  data  of 
222.74 bpm (Sreekala et al., 1991), measured for 
D. magna in a 29.5 C H2O medium.  D. magna 
in an 0.342 M EtOH medium, 3.2 mg/mL APAP 
medium, and EtOH and APAP (0.342 M +  3.2 
mg/mL) combined medium experienced a 52%, 
31%, and 27% decrease in heart rate compared 
to control, respectively.  
The  use  of  the  3.2  mg/mL  APAP 
solution  ensured  the  vitality  of  D.  magna.  
Previous experiments with D. magna have found 
48 hour EC50 values of 9.2 mg/L (Kühn et al., 
1989), 50 mg/L (Henschel et al., 1997), and 30.1 
mg/L (Kim et al., 2007).  These EC50 values 
represent the APAP concentration where 50% of 
its maximal effect is observed in 48 hours.  A 
more potent concentration of 3.2 mg/mL APAP 
was chosen to visualize a considerable change in 
heart  rate  over  a  shorter  time  span  of  five 
minutes.  Previous experiments administered a 
continuous  supply  of  lower  concentrations,  a 
method that is not normally practiced in humans. 
The 3.2 mg/mL APAP concentration was chosen 
on  the  basis  that  humans  take  a  concentrated 
amount  of  APAP  in  one  dose  in  order  to 
alleviate general pains.  
The original hypothesis was that the D. 
magna  exposed  to  toxic  doses  of  the  EtOH-
APAP  combined  solution  would  have  a 
synergistic depressant effect, resulting in a heart 
rate lower than those tested with APAP or EtOH 
alone.  However, our findings demonstrate that 
the administration of the EtOH-APAP combined 
solution  resulted  in  a  heart  rate  similar  to  D. 
magna  treated  with  only  APAP.    Since  both 
APAP  and  EtOH  can  have  inhibitory  effects 
(Smith et al., 2009; Theile et al., 2008) on the 
nervous system, the two substances may operate 
on similar pathways. 
Therefore,  since  we  now  suggest  that 
APAP  and  EtOH  utilize  similar  pathways,  the 
presence of one substance could mask the effects 
of the other.  In this case, the effect of EtOH was 
found to be masked by the presence of APAP, 
potentially explaining the similar average heart 
rate of D. magna treated with the EtOH-APAP 
solution and D. magna treated with APAP alone.  
More  research  must  be  conducted  to  better 
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understand the interaction of the two inhibitory 
pathways involved in EtOH and APAP nervous 
system responses.    
The  decreased  heart  rate  of  D.  magna 
administered with an EtOH-APAP solution was 
approximately the same as that of the D. magna 
treated  with  APAP  alone.    Interestingly,  this 
finding  suggests  that  in  regards  to  the  CNS, 
simultaneously  consuming  EtOH  and  products 
containing APAP will generate the same effect 
as ingesting APAP alone.   This conclusion does 
not  take  into  account  the  possible  effects  on 
other systems of the body caused by the intake 
of the two substances concurrently.  
Previous  research  shows  compelling 
evidence that the stomach and liver are damaged 
when  EtOH  and  APAP  are  consumed  in 
combination  (U.S.  Food  and  Drug 
Administration,  2003).    However,  there  is 
limited research demonstrating the effects of the 
two  substances  on  the  nervous  system,  thus 
further studies are necessary to fully understand 
the effects of this combination on the CNS. 
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